balance

Lithium, an anti-depressant pill commonly prescribed to treat mood swings, bipolar disorder, and depression may be a new pharmaceutical weapon that could reduce the risk of Parkinson’s disease, finds a new study.

Severe symptoms of PD, an often disabling condition, can be eased by lithium, results of an animal study show.

Researchers from Queensland University of Technology in Brisbane, Australia, stated that a few simple tests could predict the risks of falls in highly vulnerable Parkinson’s patients.

Parkinson’s disease (PD) is a degenerative disorder of the central nervous system resulting in impaired motor skills, speech, and other functions in the sufferer.